STACI OERTLE: Open Payments
NPI 1457697294 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 54 payments from 22 companies in 2025. Trend: 2023 $1,342 · 2024 $1,312 · 2025 $1,766
Food & beverage: $1,566Education: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $620 |
| Merck Sharp & Dohme LLC | 8 | $237 |
| Incyte Corporation | 4 | $183 |
| Alexion Pharmaceuticals, Inc. | 3 | $138 |
| Ipsen Biopharmaceuticals, Inc | 2 | $116 |
| TerSera Therapeutics LLC | 3 | $58 |
| ABBVIE INC. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $40 |
| ARRAY BIOPHARMA INC | 2 | $40 |
Products named: KEYTRUDA, IMFINZI, JAKAFI, DATROWAY, SOLIRIS, ENHERTU, Zoladex, Nubeqa.
Industry payments across NJ — which companies pay providers there.
